Skip to main content
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: Ophthalmology. 2010 Jan 19;117(3):484–488. doi: 10.1016/j.ophtha.2009.08.022

Figure 1.

Figure 1

Cumulative proportion of participants in the observation (OBS) group and medication (MEDS) group who developed retinal vein occlusion (RVO). The vertical line indicates the mean follow-up (yrs) completed when hypotensive medication was offered to the observation group.